Lymphedema can be defined as a long-term condition in which excess fluids accumulate in tissues leading to swelling.
Lymphedema Diagnostics Market: Introduction
- Lymphedema can be defined as a long-term condition in which excess fluids accumulate in tissues leading to swelling. Lymphedema is also known as lymphatic obstruction, which commonly affects arms and legs. Some patients even experience swelling in genitals, head, and chest.
Read Report Overview - https://www.transparencymarketresearch.com/lymphedema-diagnostics-market.html
- Two main types of lymphedema include primary lymphedema and secondary lymphedema. Primary lymphedema is also known as congenital lymphedema. Secondary lymphedema occurs due to other reasons such as cancer, inflammation, infection, injury, and trauma, among others.
- Though lymphedema is incurable, treatment is offered for reducing the swelling. The common mode of treatment employed include complex decongestive therapy. This therapy includes remedial exercises, skincare, manual lymphatic drainage, and multilayer lymphedema bandaging.
- The main cause of lymphedema is considered to be genetic mutations in genes involved in the development of the lymphatic system. Secondary causes of the disease include cancer surgery, radiation therapy, infection, and inflammatory conditions, among others.
- Lymphedema increases the risk of infections and other complications, as lymphocytes are not able to reach parts of the body where the swelling occurs
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74667
Key Drivers and Restraints of Global Lymphedema Diagnostics Market
- The prevalence of primary lymphedema is considered to be in around 1.3 children per 100,000 births in North America. The burden of secondary lymphedema is considered to be affecting around 15% to 20% of women receiving axillary dissection and/or radiotherapy as part of their breast cancer therapy. This rising prevalence of the disease is considered to drive the demand for its diagnosis, contributing to the growth of the global market.
- The prevalence of chronic limb edema is considered to be increasing with age. The prevalence is estimated to be around 1.3 people per 100,000 population and is known to affect over 5.4 people out of 1,000 patients over 65 years of age. Furthermore, the incidence of chronic arm edema after breast cancer is considered to be 22% annually, a major problem affecting one in every five breast cancer patients. This high prevalence of cancer-associated lymphedema creates a demand for its diagnosis, aiding in the growth of the lymphedema diagnostics market.
- Population aged over the age of 65 years is known to be increasing significantly and is likely to account for over 16.7% of the total population by 2050, according to the U.S. Census Bureau. Increasing prevalence rate of cancers and lymphedema contributes to the growth of the market.
Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74667
North America to Lead Global Lymphedema Diagnostics Market
- In terms of region, the global lymphedema diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global lymphedema diagnostics market, owing to increasing prevalence of cancer associated lymphedema, a well-established healthcare infrastructure, ease of availability, and rising adoption of technologically advanced diagnostic imaging systems, among others
- Europe was the second largest market for lymphedema diagnostics in 2018, followed by Asia Pacific. Asia Pacific is projected to be the rapidly growing market for lymphedema diagnostics, followed by Latin America and Middle East & Africa. This can be attributed to the rising number of diagnostic procedures, increasing incidences of chronic diseases, and growing awareness among people regarding the benefits of early diagnosis of lymphedema, among others.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=74667
Key Manufacturers Operating in Global Lymphedema Diagnostics Market
Leading players in the global lymphedema diagnostics market are:
- Siemens Healthineers
- GE Healthcare
- Stryker Corporation
- Mindray Medical International, Ltd.
Market leaders are focused on strategic agreements, partnerships, product launches, and collaborations as their key business strategies to establish and strengthen their market position in the global lymphedema diagnostics market.
Global Lymphedema Diagnostics Market: Research Scope
Global Lymphedema Diagnostics Market, by Technology
- Lymphoscintigraphy
- X-ray Lymphography
- Computed Tomography
- Magnetic Resonance Imaging
- Fluorescein Sodium Microlymphangiography
- Ultrasound Imaging
- ICG Lymphography
- Bioimpedance Analysis
- Near-infrared Fluorescence Imaging
More Trending Reports by Transparency Market Research:
Infectious Disease Diagnostics Market: Infectious diseases are caused by microorganisms such as bacteria and viruses. These microorganisms are normally harmless; however, under specific conditions, they may cause a disease. Infectious diseases can be transmitted from one person to another or they can be transmitted through animal bites.
Ovarian Cancer Diagnostics Market: Ovarian cancer is perhaps the most well-known sorts of cancer among ladies. It is a cancer that beginnings in the ovaries. Ovary is a female regenerative organ wherein eggs or ova are created. The female conceptive framework includes two ovaries: one on one or the other side of the uterus.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453